Repaglinide 135062-02-1
-
Post Date:
May 07,2019
-
Expiry Date:
Nov 03,2019
-
Detailed Description:
Cas No. :135062-02-1
Repaglinide is an antidiabetic drug in the class of medications known as meglitinides. It is an oral medication used in addition to diet and exercise for blood sugar control in type 2 diabetes mellitus.
-
CAS Registry Number:
135062-02-1
-
Synonyms:
;4-Ethoxycarbonyl-3-ethoxy phenyl acetic acid;(S)-(+)-2-Ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid;2-ethoxy-4-[2-({3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl}amino)-2-oxoethyl]benzoic acid;2-ethoxy-4-[2-({(1S)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl}amino)-2-oxoethyl]benzoic acid;
-
Molecular Formula:
C27H36N2O4
-
Molecular Weight:
452.5857
-
Molecular Structure:
Inquiry